• OPEN AN ACCOUNT
Indian Indices
Sensex
81,592.45 -318.56
( -0.39%)
Global Indices
Nasdaq
52,431.30 -76.19
(-0.15%)
Dow Jones
7,621.14 -19.24
(-0.25%)
Hang Seng
61,109.24 289.88
(0.48%)
Nikkei 225
10,863.06 27.59
(0.25%)
Forex
USD-INR
93.72 0.15
(0.16%)
EUR-INR
104.27 -0.51
(-0.49%)
GBP-INR
124.72 -0.66
(-0.52%)
JPY-INR
0.59 0.00
(-0.43%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
432.1356994
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
39.89
113912.22
EPS(TTM)
Face Value()
Div & Yield %
35.35
2
0.92
 

As on: Nov 13, 2026 03:31 PM

Last Price() Net Change (%) Volume (Nos) P / E
1,393.00 -17.00 429906 39.89
Stock Price Details
Open Price() 1,405.85
Best Buy () 1393
Best Sell () 1393.5
Buy Quantity (Nos) 1
Sell Quantity (Nos) 40
Today's High () 1,418.10
Today's Low () 1,393.00
52-Week High () 1539.25
152-Week Low () 1165.55
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.92
Eps 35.35
Book Value 432.1356994
Market Cap (.Cr) 113,912.22
Face Value 2
Market Lot 1
AGM Date Jun
Book Closure Date
ISIN No. INE059A01026


News
Cipla slips after Q2 PAT drops 35% YoY
Cipla consolidated net profit declines 35.05% in the September 2026 quarter
Cipla Ltd under sustained pressure
Cipla to announce Quarterly Result
Cipla allots 12,168 equity shares under ESOS
Cipla receives ESG rating of 68
Invagen Pharmaceuticals enters licensing agreement with Qilu
Cipla inks exclusive partnership with Qilu Pharma for commercializing Pembrolizumab in US
Cipla inks exclusive licensing agreement with SBP Group for ADC Rolditamig Deuderuxtecan
Cipla and SBP Group sign exclusive license agreement for Rolditamig Deuderuxtecan
More
Corporate Details
Incoporation Year   : 1935
Chairman : Y K Hamied
Bussiness Group : Indian Private
Registered Office
Cipla Ltd
Cipla House Peninsula Buss Par,
Ganpatrao Kadam Mg Lower Parel,
Mumbai,
Maharashtra-400013
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-22-24826000
Fax:91-22-24826120
Fax:91-22-66317458
E-Mail : cosecretary@cipla.com, contactus@cipla.com
URL : http://www.cipla.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 100
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE Shariah 50
  • NIFTY
  • CNX 500
  • CNX 100
  • CNX Pharma
  • CNX 200
  • NI15 Index
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi